Dose-effect relationship of LiCl, an inhibitor of GSK-3β, on severe acute pancreatitis in rats
Chen CHEN,Kai-liang ZHAO,Wen-hong DENG,Jia YU,Wen-yi GUO,Da-xing ZHANG,Wei-xing WANG
DOI: https://doi.org/10.3969/j.issn.1003-6350.2016.09.002
2016-01-01
Abstract:Objective To investigate dose-effect relationship of LiCl, an inhibitor of GSK-3β, on severe acute pancreatitis in rats. Methods Fifty male Wistar rats were randomly divided into 5 groups (n=10) by digital table meth-od:sham operation group (SO group), severe acute pancreatitis model group (SAP group), different dosage LiCl pretreat-ment groups (40 mg/kg, 60 mg/kg and 80 mg/kg). SAP model was induced by retrograde infusion of 5%sodium tauro-cholate (0.1 mL/100 g) into the biliopancreatic duct. In SO group, the same amount of normal saline (NS) was infused in-to bilio-pancreatic duct instead of sodium taurocholate. Various doses (40 mg/kg, 60 mg/kg and 80 mg/kg) of LiCl solu-tion were administered via femoral vein 30 min before the SAP induction in LiCl pretreatment groups. Rats were killed at 12 h after operation, and the levels of serum amylase (AMY), alanine transarninase (ALT), creatinine (Cr), ascites, lung wet/dry weight ratio were measured in all groups. Pancreatic tissue was observed under the light microscope and pathological score was evaluated. Results The levels of AMY, ALT, Cr, ascites, lung wet/dry weight ratio, and pan-creatic pathological score in SAP group were significantly higher than those in SO groups (7224.14±1872.41) U/L vs (1780.21±231.12) U/L, (250.56±51.56) U/L vs (98.45±10.36) U/L, (85±19) U/L vs (36±4) U/L, (11.05±2.76) g vs (0.33±0.04) g, (3.21±0.61) vs (1.60±0.20), (11.52±1.23) vs (0.54±0.02) (P<0.05). Compared with SAP group, 60 mg/kg dosage of LiCl had the best effect on improving all the indexes [(4215.36 ± 940.24) U/L vs (7224.14 ± 1872.41) U/L, (160.25 ± 35.39) U/L vs (250.56±51.56) U/L, (50±11) U/L vs (85±19) U/L, (6.04±1.03) g vs (11.05±2.76) g, (2.70±0.54) vs (3.21±0.61), (9.03±1.09) vs (11.52 ± 1.23), P<0.05], while 40 mg/kg dosage of LiCl failed to improve some indexes (AMY, ascites, lung wet/dry weight ratio, pathological score) (P>0.05). However, ALT level of LiCl 80 mg/kg group was higher than SAP group [(312.47 ± 69.41) U/L vs (250.56 ± 51.56) U/L, P<0.05], and there was no significant difference of Cr level between the two groups [(79 ± 17) U/L vs (85 ± 19) U/L, P>0.05]. Conclusion LiCl (60 mg/kg) administered intravenously was the optimal and effective dosage for attenuating the severity of severe acute pancreatitis.